Henrik Hellborg

1.6k citations

24 papers · 1.2k indexed · h-index 18

Impact in

Oncology top 5%
- Cutaneous Melanoma Detection and Management
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Cancer Research top 5%
- Breast Cancer Treatment Studies

Papers in ⓘ

Oncology 13
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 2
- Cutaneous Melanoma Detection and Management 2
- Colorectal Cancer Treatments and Studies 2
Cancer Research 8
- Breast Cancer Treatment Studies 7

Co-authors: Lambert Skoog (7 shared papers)Barbro Linderholm (4 shared papers)Göran Elmberger (4 shared papers)Janne Lehtiö (2 shared papers)Unn‐Britt Johansson (2 shared papers)Rolf Lewensohn (1 shared paper)Jan Adolfsson (5 shared papers)Edoardo Colzani (1 shared paper)
Journals: European Journal of Cancer (3 papers)Breast Cancer Research and Treatment (3 papers)Annals of Oncology (2 papers)Journal of Clinical Oncology (2 papers)European Urology (2 papers)
Partner nations: Sweden Thailand United Kingdom

In The Last Decade

Henrik Hellborg

24 papers receiving 1.1k citations

Peers

Countries citing papers authored by Henrik Hellborg

Since Specialization

Citations

This map shows the geographic impact of Henrik Hellborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Hellborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Hellborg more than expected).

Fields of papers citing papers by Henrik Hellborg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Hellborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Hellborg. The network helps show where Henrik Hellborg may publish in the future.

Co-authors

The 25 scholars most cited alongside Henrik Hellborg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Henrik Hellborg Line = papers co-authored together Henrik Hellborg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer Annals of Oncology ·Barbro Linderholm, Henrik Hellborg, Unn‐Britt Johansson, Göran Elmberger, Lambert Skoog, Janne Lehtiö, Rolf Lewensohn	2009	266
2	Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics Journal of Clinical Oncology ·Edoardo Colzani, Annelie Liljegren, Anna L.V. Johansson, Jan Adolfsson, Henrik Hellborg, P.F. Hall, Kamila Czene	2011	160
3	2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial The Lancet ·Peter Gillgren, Krzysztof T. Drzewiecki, Marianne Niin, Hans Petter Gullestad, Henrik Hellborg, Eva Månsson‐Brahme, Christian Ingvar, Ulrik Ringborg	2011	138
4	Metastatic Potential in Renal Cell Carcinomas ≤7cm: Swedish Kidney Cancer Quality Register Data European Urology ·Eirikur Guðmundsson, Henrik Hellborg, Sven Lundstam, Stina Erikson, Börje Ljungberg	2011	83
5	Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden Breast Cancer Research and Treatment ·Theodoros Foukakis, Tommy� Fornander, Tobias Lekberg, Henrik Hellborg, Jan Adolfsson, Jonas Bergh	2011	60
6	Paget’s disease of the nipple in a population based cohort Breast Cancer Research and Treatment ·Kristina Dalberg, Henrik Hellborg, Fredrik Wärnberg	2007	59
7	Bilateral Prophylactic Mastectomy in Swedish Women at High Risk of Breast Cancer Annals of Surgery ·Brita Arver, Karin Isaksson, Hans Atterhem, Annika Baan, Leif Bergkvist, Yvonne Brandberg, Hans Ehrencrona, Monica Emanuelsson, Henrik Hellborg, Karin Henriksson, Per Karlsson, Niklas Loman, Jonas Lundberg, Anita Ringberg, Marie Stenmark Askmalm, Marie Wickman, Kerstin Sandelin	2011	51
8	Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer Colorectal Disease ·Josefin Segelman, T Singnomklao, Henrik Hellborg, Anna Martling	2008	44
9	Activated ERK1/2 and phosphorylated oestrogen receptor α are associated with improved breast cancer survival in women treated with tamoxifen European Journal of Cancer ·Jenny Bergqvist, Göran Elmberger, John Öhd, Barbro Linderholm, Judith Bjöhle, Henrik Hellborg, Hans Nordgren, Anna-Lena Borg, Lambert Skoog, Jonas Bergh	2006	43
10	Epidemiology and prognosis of ovarian metastases in colorectal cancer British journal of surgery ·Josefin Segelman, Angelique Flöter Rådestad, Henrik Hellborg, Annika Sjövall, Anna Martling	2010	37
11	An expression signature at diagnosis to estimate prostate cancer patients’ overall survival Prostate Cancer and Prostatic Diseases ·Zheng Peng, Lambert Skoog, Henrik Hellborg, Gustaf Jonstam, I-L Wingmo, Marie Hjälm-Eriksson, Ulrika Harmenberg, Gabriella Cohn Cedermark, Karl Andersson, (unknown), Setia Pramana, Yudi Pawitan, Monica Nistér, Sten Nilsson, Chunde Li	2014	33
12	Esophageal stricture after radiotherapy in patients with head and neck cancer: Experience of a single institution over 2 treatment periods Head & Neck ·Alexander Ahlberg, Massoud al‐Abany, Eleftheria Alevronta, Signe Friesland, Henrik Hellborg, Panayiotis Mavroidis, Bengt K. Lind, Göran Laurell	2009	31
13	Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome Annals of Oncology ·Jenny Bergqvist, John Öhd, Johanna Smeds, Sigrid Klaar, Jorma Isola, Hans Nordgren, Göran Elmberger, Henrik Hellborg, Judith Bjöhle, Alexander Borg, Lambert Skoog, Jonas Bergh	2007	31
14	Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe Sweden European Journal of Cancer ·Andreas Thorstenson, Ola Bratt, Olof Akre, Henrik Hellborg, Lars Holmberg, Mats Lambe, Anna Bill‐Axelson, Pär Stattin, Jan Adolfsson	2012	30
15	Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factor Medical Oncology ·Barbro Linderholm, Jenny Bergqvist, Henrik Hellborg, Unn‐Britt Johansson, Mats Linderholm, E. von Schoultz, Göran Elmberger, Lambert Skoog, Jonas Bergh	2009	21
16	ProMIS ^™ Can Serve as a da Vinci ^® Simulator—A Construct Validity Study Journal of Endourology ·Martin Jonsson, Mahmood Mahmood, T. Askerud, Henrik Hellborg, Stig Ramel, Peter Wiklund, Magnus Kjellman, Gunnar Ahlberg	2010	21
17	Interobserver Variability of Histopathological Prognostic Parameters in Cutaneous Malignant Melanoma: Impact on Patient Management Acta Dermato Venereologica ·Hanna Eriksson, Margareta Frohm‐Nilsson, Mari‐Anne Hedblad, Henrik Hellborg, Lena Kanter‐Lewensohn, Kamilla Krawiec, Barbro Lundh Rozell, Eva Månsson‐Brahme, Johan Hansson	2013	20
18	Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer Breast Cancer Research and Treatment ·Barbro Linderholm, Henrik Hellborg, Ulla Johansson, Lambert Skoog, Janne Lehtiö	2010	19
19	When does my treatment start? – The continuum of care for patients with head and neck cancer Radiotherapy and Oncology ·Lena Sharp, Freddi Lewin, Henrik Hellborg, Jan Lundgren, Erik Hemmingsson, Lars Erik Rutqvist	2002	13
20	Reply from Authors re: Eric C. Umbreit, R. Houston Thompson. Metastatic Potential of the Small Renal Mass: Why Can’t We Agree? Eur Urol 2011;60:983–5 European Urology ·Börje Ljungberg, Eirikur Guðmundsson, Henrik Hellborg, Stina Erikson, Sven Lundstam	2011	2

About Henrik Hellborg

Henrik Hellborg is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Surgery, having authored 24 papers that have together received 1.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Prostate Cancer Treatment and Research (4 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Treatment and Pharmacology (2 papers), Cutaneous Melanoma Detection and Management (2 papers), Genetic factors in colorectal cancer (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Oncology (667 citations), Cancer Research (355 citations), Pulmonary and Respiratory Medicine (293 citations), Dermatology (79 citations) and Otorhinolaryngology (28 citations). Henrik Hellborg has collaborated with scholars based in Sweden, Thailand and United Kingdom. Frequent co-authors include Lambert Skoog, Barbro Linderholm, Göran Elmberger, Janne Lehtiö, Unn‐Britt Johansson, Rolf Lewensohn, Jan Adolfsson, Edoardo Colzani, Kamila Czene and Anna L.V. Johansson. Their work appears in journals such as European Journal of Cancer, Breast Cancer Research and Treatment, Annals of Oncology, Journal of Clinical Oncology and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact